TVARDI THERAPEUTICS, INC. Restructuring Charges
TVARDI THERAPEUTICS, INC. (TVRD) reported Restructuring Charges of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. restructuring charges for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- TVARDI THERAPEUTICS, INC. restructuring charges for the quarter ending 2024-12-31 was -$124.00K.
- TVARDI THERAPEUTICS, INC. restructuring charges for the quarter ending 2024-09-30 was $707.00K.
- TVARDI THERAPEUTICS, INC. restructuring charges for the quarter ending 2024-06-30 was $2.58M.
- TVARDI THERAPEUTICS, INC. restructuring charges for fiscal 2024 was $5.57M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | -$124.00K derived: sum of 2 quarters · filed 2025-05-13 | $583.00K derived: sum of 3 quarters · filed 2025-05-13 | $3.16M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $583.00K derived: sum of 2 quarters · filed 2025-03-11 | $3.16M derived: sum of 3 quarters · filed 2025-03-11 | $5.57M 10-K · filed 2025-03-11 |
| 2024-09-30 | $707.00K 10-Q · filed 2024-11-14 | $3.29M derived: sum of 2 quarters · filed 2024-11-14 | $5.69M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.58M 10-Q · filed 2024-08-14 | $4.98M 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $2.40M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |